CN110551129A - preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester - Google Patents

preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester Download PDF

Info

Publication number
CN110551129A
CN110551129A CN201910664445.2A CN201910664445A CN110551129A CN 110551129 A CN110551129 A CN 110551129A CN 201910664445 A CN201910664445 A CN 201910664445A CN 110551129 A CN110551129 A CN 110551129A
Authority
CN
China
Prior art keywords
compound
preparation
reaction
steps
following
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910664445.2A
Other languages
Chinese (zh)
Other versions
CN110551129B (en
Inventor
刘月领
任文武
周强
徐富军
王瑞琪
陈佩
张莉莉
李贺山
安自强
杨芳
何燕平
刘胜攀
于凌波
马汝建
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changzhou Hequan Pharmaceutical Co Ltd
Original Assignee
Changzhou Hequan Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changzhou Hequan Pharmaceutical Co Ltd filed Critical Changzhou Hequan Pharmaceutical Co Ltd
Priority to CN201910664445.2A priority Critical patent/CN110551129B/en
Publication of CN110551129A publication Critical patent/CN110551129A/en
Application granted granted Critical
Publication of CN110551129B publication Critical patent/CN110551129B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

2The invention relates to a preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester, which mainly solves the technical problem that no industrial synthesis method is available at present.

Description

Preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester
Technical Field
The invention relates to a preparation method of 2-tert-butyl dihydropyrrolodiazepine dicarboxylate, namely a synthesis method of 2-tert-butyl 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylate (CAS: 1251017-62-5).
Background
4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester and related derivatives have wide application in pharmaceutical chemistry and organic synthesis, and are important medical intermediates. At present, few reports about the synthesis of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester exist, the reaction route is long like the literature, the yield is low, and the method is not suitable for large-scale production in factories. Therefore, it is necessary to develop a synthesis method with easily available raw materials, convenient operation, easily controlled reaction and suitable overall yield.
Disclosure of Invention
The invention aims to develop a synthetic method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester, which has the advantages of easily obtained raw materials, convenient operation, easily controlled reaction and higher yield. Mainly solves the technical problem that no industrial synthesis method is available at present.
The technical scheme includes that the preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester comprises the following steps of firstly dissolving a compound 1 in acetonitrile to react with the compound 2 under the action of potassium carbonate at room temperature to generate a compound 3, secondly, adding sodium borohydride into ethanol to reduce and amine the compound 2 and benzylamine and closing a ring to obtain a compound 4, then adding 10% palladium into an ethanol solution of the compound 4 to remove a benzyl protection group of the compound 4 through hydrogen to obtain a compound 5, then reacting with BOC 2 O in a methanol solution of the compound 5 to obtain a compound 6, and finally adding sodium hydroxide into a mixed solvent of methanol and water to hydrolyze the compound 6 to obtain a final product 7, wherein the reaction formula is as follows:
The reaction temperature of the first step is 20 ℃, and the reaction time is 12 hours; the second step is that the reaction is carried out for 1 hour at 20 ℃ and then for 12 hours at 80 ℃; the third step is that the reaction is carried out for 20 hours under the conditions of 40 ℃ and 50 psi; the fourth step is reaction at 20 ℃ for 12 hours; the fifth step is carried out at 20 ℃ for 1 hour.
The invention has the beneficial effects that: the invention provides a method for synthesizing 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester, which has the advantages of short synthetic route, 16.8% yield, easy amplification of reaction, convenient operation and industrial application prospect.
Detailed Description
The reaction formula of the invention is as follows:
Example 1: a. compound 1 (100.00 g, 1.05 mol) was dissolved in acetonitrile (500 mL), potassium carbonate (218.00 g, 1.58 mol) was added and stirred for half an hour, then Compound 2 was added dropwise slowly at 0 ℃ and the reaction was stirred for 12 hours at 20 ℃ after the completion of the addition. TLC (petroleum ether/ethyl acetate volume ratio = 2/1) showed the reaction was complete. Water was added to the reaction system, followed by extraction with ethyl acetate three times, and the combined organic phases were purified by silica gel column chromatography to give compound 3 (186.83 g, 901.56 mmol) with a yield of 85.86%.
b. compound 3 (186.83 g, 901.56 mmol) and benzylamine (106.26 g, 991.71 mmol) are dissolved in ethanol (500 mL) and reacted at 20 ℃ for half an hour, followed by addition of sodium borohydride (20.46 g, 540.94 mmol) and stirring at 20 ℃ for an additional 30 minutes. TLC (petroleum ether/ethyl acetate volume ratio =5/1) showed complete consumption of starting material. The reaction solution was heated to 80 ℃ and stirred at that temperature for 12 hours. The reaction solution was quenched with water (200 mL), and distilled under reduced pressure to give a crude product, which was then purified by silica gel column chromatography to give compound 4 (52.00 g, 174.27 mmol) as a white solid in 19.33% yield.
c. Compound 4 (47.90 g, 160.53 mmol) was dissolved in ethanol (800 mL), 10g of 10% palladium on carbon was added, hydrogen gas was substituted 3 times, and the reaction was carried out at 40 ℃ under 50 psi for 20 hours. TLC (petroleum ether/ethyl acetate volume ratio =5/1) showed the starting material was reacted. The reaction was filtered and the filtrate was concentrated under reduced pressure to give crude compound 5, which was used directly in the next step.
d. Compound 5 (33.43 g, 160.52 mmol) was dissolved in ethanol (500 mL) and tert-butoxycarbonylanhydride (38.54 g, 176.57 mmol) was added dropwise. The reaction solution was stirred at 20 ℃ for 12 hours. TLC (dichloromethane/methanol volume ratio = 10/1) showed the reaction was complete. The reaction was concentrated under reduced pressure, water (200 mL) was added, and the mixture was extracted with dichloromethane (100 mL. times.3). The organic phase was dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give crude compound 6(60.00 g, crude) as a yellow oil, which was used directly in the next step.
e. Compound 6 (41.40 g, 134.25 mmol, 1.00 Eq) was dissolved in methanol (210 mL) and water H 2 O (70 mL), sodium hydroxide (26.85 g, 671.25 mmol) was added to the reaction system, stirring was carried out at 20 ℃ for 1 hour TLC (petroleum ether/ethyl acetate volume ratio =5/1) showed the reaction was complete the reaction solution was concentrated under reduced pressure, then washed with ethyl acetate (200 mL), the aqueous phase was dissolved with 1M dilute hydrochloric acid to adjust pH to 4-5, then extracted with dichloromethane (200 mL x 3), the dichloromethane phases were combined, dried over anhydrous sodium sulfate, filtered and spun dry to give the desired compound 4, 5-dihydro-1H, 3H-pyrrolo [1,2-a ] [1,4] diazepine-2, 4-dicarboxylic acid 2-tert-butyl ester as a white solid (33.20 g, 118.44 mmol, 88.22% yield).
δ6.62 (s, 1 H), 6.24-5.91 (m, 2 H), 4.73 (d, J=15.44 Hz, 1 H), 4.32 (d, J=14.11 Hz, 2 H), 4.29-3.93 (m, 2 H), 3.57-3.25 (m, 1 H), 2.92 (s, 1 H),1.54-1.36 (m, 9 H)。

Claims (6)

1. A preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester is characterized by comprising the following steps of firstly dissolving a compound 1 in acetonitrile to react with a compound 2 under the action of potassium carbonate at room temperature to generate a compound 3, secondly adding sodium borohydride to ethanol for reductive amination and ring closing to obtain a compound 4, thirdly adding 10% palladium carbon to ethanol solution of the compound 4 to remove a benzyl protection group of the compound 4 through hydrogen introduction to obtain a compound 5, fourthly reacting with BOC 2 O in methanol solution of the compound 5 to obtain a compound 6, and fifthly adding sodium hydroxide to the compound 6 in a mixed solvent of methanol and water to hydrolyze the compound 6 to obtain a final product 7, wherein the reaction formula is as follows:
2. The method of claim 1, wherein the preparation method comprises the following steps: the reaction temperature of the first step is 20 ℃, and the reaction time is 12 hours.
3. The method of claim 1, wherein the preparation method comprises the following steps: in the second step, the reaction was carried out at 20 ℃ for 1 hour and then at 80 ℃ for 12 hours.
4. The method of claim 1, wherein the preparation method comprises the following steps: in the third step, the reaction is carried out for 20 hours at the temperature of 40 ℃ and under the condition of 50 psi.
5. The method of claim 1, wherein the preparation method comprises the following steps: the fourth step is carried out at 20 ℃ for 12 hours.
6. The method of claim 1, wherein the preparation method comprises the following steps: the reaction temperature in the fifth step was 20 ℃ and the reaction time was 1 hour.
CN201910664445.2A 2019-07-23 2019-07-23 Preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester Active CN110551129B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910664445.2A CN110551129B (en) 2019-07-23 2019-07-23 Preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910664445.2A CN110551129B (en) 2019-07-23 2019-07-23 Preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester

Publications (2)

Publication Number Publication Date
CN110551129A true CN110551129A (en) 2019-12-10
CN110551129B CN110551129B (en) 2021-11-09

Family

ID=68735848

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910664445.2A Active CN110551129B (en) 2019-07-23 2019-07-23 Preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester

Country Status (1)

Country Link
CN (1) CN110551129B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007117180A1 (en) * 2006-04-12 2007-10-18 'chemical Diversity Research Institute' Ltd. Azaheterocycles, combinatory library, focused library, pharmaceutical composition and methods for the production thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007117180A1 (en) * 2006-04-12 2007-10-18 'chemical Diversity Research Institute' Ltd. Azaheterocycles, combinatory library, focused library, pharmaceutical composition and methods for the production thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANDREW J. MUSACCHIO ET AL.: "Catalytic Olefin Hydroamination with Aminium Radical Cations: A Photoredox Method for Direct C−N Bond Formation", 《J. AM. CHEM. SOC.》 *
RICHARD G. DOVESTON ET AL.: "A unified lead-oriented synthesis of over fifty molecular scaffolds", 《ORGANIC & BIOMOLECULAR CHEMISTRY》 *
SUNG-KEE CHUNG ET AL.: "A diastereoselective phenylselenium-induced lactamization of olefinic amides. A possible route to or-and [5-amino acid derivatives", 《TETRAHEDRON: ASYMMETRY》 *

Also Published As

Publication number Publication date
CN110551129B (en) 2021-11-09

Similar Documents

Publication Publication Date Title
CN108129288B (en) Synthesis method of trans-3-hydroxycyclobutylformic acid
CN111620869B (en) Synthesis method of tert-butyl-1, 7-diazaspiro [3.5] nonane-1-formyloxy ester
CN110330500B (en) Stereoselective synthesis method of 6 beta-hydroxy-7, 8-dihydro-morphine derivative
CN107383026B (en) A kind of synthetic method of 7- methylol -2,5- diaza spiro [3,4] octane -2- t-butyl formate
CN110551133A (en) Process for preparing tert-butyl-5- (hydroxymethyl) -7-oxa-2-azaspiro [3.5] nonane-2-carboxylic acid ester
CN112645833A (en) Synthesis method of (S) -2, 6-diamino-5-oxohexanoic acid
CN111533745A (en) Process for preparing tert-butyl-3- (aminomethyl) dihydro-5H-triazolodiazepine-8 (9H) -carboxylic acid ester
CN110551129B (en) Preparation method of 4, 5-dihydro-1H, 3H-pyrrolo [1,2-A ] [1,4] diazepine-2, 4-dicarboxylic acid-2-tert-butyl ester
CN110551123A (en) Preparation method of 5- (tert-butyloxycarbonyl) -2-methyl-4, 5,6, 7-tetrahydro-2H-pyrazolo [4,3-C ] pyridine-7-carboxylic acid
CN107216332B (en) The synthetic method of 5 (6H) formic acid base ester of tert-butyl -7- methylol -7,8- dihydro 4H pyrazolo diazepine
CN107216335B (en) A kind of tert-butyl 1- (methylol) -3- oxa- -9- azaspiro [5.5] hendecane -9- formic acid base ester preparation method
CN111548356B (en) Process for preparing tert-butyl-1, 8-dioxa-4, 11-diazaspiro [5.6] dodecane-11-carboxylic acid ester
CN112679512B (en) Trabectedin intermediate and preparation method thereof
CN109369442B (en) Preparation method of beta-N-methylamino-L-alanine
CN111574524B (en) 2- (tert-butoxycarbonyl) -7-oxyylidene-2, 6-diazaspiro [3.4] octane-5-carboxylic acid preparation method
CN111620877B (en) Process for preparing 1-benzyl-5- (tert-butyloxycarbonyl) octahydropyrrolopyrrole-2-carboxylic acid
CN110563687B (en) Preparation method of 4- (aminomethyl) chroman-3-ol
CN107312011A (en) The synthetic method of the carboxylic acid of 2,7 diaza spiro nonane of racemic 7 tert-butoxycarbonyl, 1 oxygen subunit 4
CN110790708B (en) Preparation method of Ailixipine intermediate
CN114105848B (en) Preparation method of cis-D-hydroxyproline derivative
CN107383035A (en) 2 ((1S3aR7aR) 5 tertbutyloxycarbonyl tetrahydrofuran simultaneously [3,4] piperidinyl-1) acetic acid preparation methods
CN115417803B (en) Synthesis method of Wu Pa tenib intermediate (3R, 4S) -1-benzyloxycarbonyl-4-ethylpyrrolidine-3-carboxylic acid
CN112679513B (en) Method for preparing key intermediate of koji Bei Ti
CN110483534B (en) Preparation method of (2,4,5, 7-tetrahydropyrano [3,4-c ] pyrazol-7-yl) methanol
CN111808040B (en) Synthesis method of multi-configuration 2-oxo-oxazolidine-4-carboxylic acid compounds

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant